Public sector must develop drugs for neglected diseases

BMJ 2002; 324 doi: (Published 23 March 2002) Cite this as: BMJ 2002;324:698
  1. Gavin Yamey
  1. Oakland

    Western society's decision to leave drug development in the hands of the private sector has led to a crisis for the world's poor, because the private sector has failed to develop or distribute drugs to treat infectious diseases in the poorest regions of the world. A new public sector initiative is urgently needed to …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription